ZTTA, a prolyl endopeptidase inhibitor, potentiates the arginine-vasopressin-induced incorporation of [14C]leucine in rat amygdaloid and cortical slices.
Shishido
Y
Y
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. byg00625@nifty.ne.jp
Tanaka
T
T
Tanabe
S
S
Furushiro
M
M
Hashimoto
S
S
Yokokura
T
T
Shibata
S
S
Watanabe
S
S
D000679:Amygdala / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D001127:Arginine Vasopressin / Q000494:pharmacology; D002250:Carbon Radioisotopes; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007930:Leucine / Q000378:metabolism; D008297:Male; D010452:Peptide Biosynthesis / Q000187:drug effects*; D000085822:Prolyl Oligopeptidases; D051381:Rats; D017208:Rats, Wistar; D012697:Serine Endopeptidases / Q000187:drug effects / Q000378:metabolism*; D013844:Thiazoles / Q000494:pharmacology*
D002250:Carbon Radioisotopes; D004791:Enzyme Inhibitors; C105467:N-benzyloxycarbonyl-thioprolyl-thioprolinal-dimethylacetal; D013844:Thiazoles; D001127:Arginine Vasopressin; D012697:Serine Endopeptidases; D000085822:Prolyl Oligopeptidases; D007930:Leucine